My reviews
Where I see patients (1)
Selected research
-
BCMA-directed CAR T-cell Therapy in patients with multiple myeloma and CNS involvement.
Blood advances
-
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.
Blood
-
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma.
Blood advances
Clinical trials
Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocat...
A dose limiting toxicity (DLT) will be defined as an adverse event that are considered by the investigator to be at least possibly related to the study drugs and are observed within the DLT assessment window (Cycle 1, Days 1 to 28...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9